Threshold Pharmaceuticals Receives Two U.S. Patents for Tarloxotinib Bromide
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/13/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the first two U.S. patents protecting tarloxotinib bromide*, or " …